Trial Profile
Post-Operative Alertness and Recovery. Sugammadex Versus Neostigmine/Glycopyrrolate and Placebo
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2013
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 22 Oct 2013 New trial record
- 16 Oct 2013 Results presented at the 2013 Annual Meeting of the American Society of Anesthesiologists.